Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6701 USD | -1.90% | -16.13% | -52.48% |
Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.48% | 32.33M | |
+72.64% | 12.34B | |
-18.30% | 7.96B | |
+15.38% | 7.16B | |
+2.18% | 5.72B | |
+6.51% | 5.03B | |
+21.99% | 4.35B | |
-22.12% | 3.99B | |
-41.36% | 2.21B | |
+0.87% | 2.01B |
- Stock Market
- Equities
- LUCD Stock
- News Lucid Diagnostics Inc.
- Lucid Diagnostics : Prices IPO at $14 Per Share